Greg, Boss
Department of Diabetes & Endocrinology
CSL Behring
Austria
Biography
Greg joined CSL in 2001, serving as U.S. General Counsel for CSL’s sales and distribution business, ZLB Bioplasma. In this role, he was instrumental in the company’s acquisition and integration of industry competitor Aventis Behring, and upon the integration of the two companies in 2004, Greg assumed the global General Counsel position for the combined business.
Research Interest
Research, Pharmaceuticals, Biotechnology, Healthcare, Medical Science
